$36.70
-2.8%Astrana Health, Inc., Inc., a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients. It offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans. The company's physician network consists of primary care physicians, specialist physicians and extenders, and hospitalists. It serves patients, primarily covered by private or public insurance, such as Medicare, Medicaid, and health maintenance organization plans; and non-insured patients. The company was formerly known as Apollo Medical Holdings, Inc. and changed its name to Astrana Health, Inc. in February 2024. Astrana Health, Inc. was incorporated in 1985 and is headquartered in Alhambra, California.
Chief Accounting Officer & Principal Accounting Officer
Chief Financial Officer, Chief Operating Officer & Corporate Secretary
Compensation
$1,253,374
Chief Medical Officer
Compensation
$1,737,826
Chief People Officer
Chief Quality Officer
Co-Founder & Executive Chairman
Compensation
$970,866
Co-Founder & Vice Chairman
Compensation
$964,662
President & Chief Executive Officer
Compensation
$2,349,359
President of Provider Solutions
Senior Vice President of Health Affairs
Compensation
$452,281
During the last 12 months, insiders have purchased $364K worth of ASTH shares, with no selling activity reported.
0
0.00
0
0.00
+0
+$0
0
0.00
0
0.00
+0
+$0
20.0K
364.00K
0
0.00
+364K
+$364K
0
0.00
0
0.00
+0
+$0
Marsh Linda
Director
$364K
No selling activity
Strong bullish signal with $364K net buying. Insiders are aggressively accumulating shares, suggesting significant confidence in future prospects.
Perfect buy/sell ratio. Only buying activity with zero selling—the most bullish possible insider signal.
1 insider buyers vs. 0 sellers. Broad-based buying across management team suggests widespread confidence.
Unanimous insider buying: Zero selling combined with active buying is rare and typically very bullish. Insiders appear to see significant upside with limited downside risk.
ASTH - Filing history and reports
| Filing Type | Filing Date | Period Ending | Fiscal Year | Actions |
|---|---|---|---|---|
DEF 14A DEF 14A 2026 N/A | April 17, 2026 | June 10, 2026 | 2026 | |
DEF 14A DEF 14A 2025 N/A | April 25, 2025 | June 11, 2025 | 2025 | |
DEF 14A DEF 14A 2024 N/A | April 24, 2024 | June 12, 2024 | 2024 | |
DEF 14A DEF 14A N/A | April 28, 2023 | April 28, 2023 | ||
DEF 14A DEF 14A 2022 N/A | April 29, 2022 | April 29, 2022 | 2022 | |
DEF 14A DEF 14A 2020 N/A | April 29, 2021 | December 31, 2020 | 2020 | |
DEF 14A DEF 14A 2020 N/A | April 29, 2020 | June 15, 2020 | 2020 | |
DEF 14A DEF 14A 2019 N/A | July 31, 2019 | August 27, 2019 | 2019 | |
DEF 14A DEF 14A 2019 N/A | April 30, 2019 | June 17, 2019 | 2019 | |
DEF 14A DEF 14A 2018 N/A | April 30, 2018 | June 18, 2018 | 2018 |
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.